MARKET NEWS

 

FDA Approves First & Only Oral Somatostatin Analog for Acromegaly
Intra-Cellular Therapies Announces Positive Top-line Results from Phase 1/2 Study
Aptose Announces FDA Allowance of IND for Phase 1a/b Study
Oncology Venture Signs Agreement to Out-License Two Pipeline Assets
Novartis Announces MET inhibitor Approved in Japan for Advanced Non-Small Cell Lung Cancer With METex14
Bormioli Pharma Invests in Type I Glass Vial Production for Injectable Medicines & Vaccines
Provectus Biopharmaceuticals Announces Discovery of Unique PV-10-Induced STING Pathway Mechanism
Catalent Partners With ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study
uniQure Announces First Two Patients Treated in Phase 1/2 Clinical Trial

  FEATURED EDITORIAL

  COMPANY PROFILE

AbbVie Contract Manufacturing

ABITEC Corporation

Adare Pharmaceuticals

Ajinomoto Bio-Pharma Services

Alcami

ARL Bio Pharma

Ascendia Pharmaceuticals

BASF Corporation

Baxter BioPharma Solutions

BD Medical – Pharmaceutical Systems

BioDuro

Bioiberica S.A.U

Capsugel – Lonza

Captisol, a Ligand Company

Catalent Pharma Solutions

Credence MedSystems Inc.

Croda Health Care

Datwyler Pharma Packaging USA Inc.

DDL

Element Materials Technology

Eurofins BioPharma Product Testing

Excite Pharma Services

Foster Delivery Science

Frontage Laboratories, Inc.

Gattefosse

Haselmeier, Inc.

HERMES PHARMA

ILC Dover

Integral BioSystems LLC

JRS Pharma

Lonza Pharma & Biotech

Lubrizol Life Science Health

Lyophilization Technology, Inc.

Metrics Contract Services

MilliporeSigma

Mitsubishi Gas Chemical Company, Inc.

Nemera

Noble

Pace Analytical Life Sciences

Pfanstiehl

Pfizer CentreOne

PharmaCircle

Pii

PMI Biopharma Solutions

Portal Instruments

Proveris Scientific

Quotient Sciences

Recipharm

SGS Life Sciences

SGW Pharma Marketing

Singota Solutions

Vetter Pharma International

Yourway

 

  EXCLUSIVE ONLINE CONTENT

Ajinomoto Bio-Pharma Services Introduces AJILITY Fast-Track Platform for Drug Product Manufacturing

Ajinomoto Bio-Pharma Services Introduces AJILITY Fast-Track Platform for Drug Product Manufacturing

Ajinomoto Bio-Pharma Services recently announce the launch of AJILITY, a flexible and agile drug product manufacturing platform, designed to advance….

Bioasis & Chiesi Group Announce Rare Diseases Strategic Alliance

Bioasis & Chiesi Group Announce Rare Diseases Strategic Alliance

Bioasis Technologies, Inc. and Chiesi Global Rare Diseases recently announced they have entered into a worldwide, exclusive licensing agreement for the….

RedHill Biopharma Receives Approval for COVID-19 Phase 2/3 Study

RedHill Biopharma Receives Approval for COVID-19 Phase 2/3 Study

RedHill Biopharma Ltd. recently announced that the UK Medicines & Healthcare products Regulatory Agency (MHRA) has approved the company’s Clinical Trial Authorization (CTA) application to commence a….

Moderna & Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate

Moderna & Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate

Moderna, Inc. and Catalent, Inc. recently announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate…..

Yumanity Therapeutics Announces Strategic Research Collaboration & License Agreement With Merck

Yumanity Therapeutics Announces Strategic Research Collaboration & License Agreement With Merck

Yumanity Therapeutics recently announced it has entered into a strategic research collaboration and license agreement with Merck focused on accelerating….

Mateon & GMP Completed Research & Service Agreement

Mateon & GMP Completed Research & Service Agreement

Mateon Therapeutics, Inc. recently announced that both Golden Mountain Partners (GMP) and Mateon have fulfilled all the obligations under the Research and Services Agreement entered on….

Esperion & Daiichi Sankyo Europe Announce Amendment to License & Commercial Collaboration Agreement

Esperion & Daiichi Sankyo Europe Announce Amendment to License & Commercial Collaboration Agreement

Esperion recently announced the completion of an amendment to the EU commercial collaboration agreement with Daiichi Sankyo Europe (DSE). ….